Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis - Ohio, 2010-2011

Clinical Infectious Diseases

Volumn 56, Issue 3, 2013, Pages 322-331

  Rodgers, Loren ^a,c   Martin, Stacey W ^b   Cohn, Amanda ^b   Budd, Jeremy ^c   Marcon, Mario ^d,e   Terranella, Andrew ^a,b   Mandal, Sema ^a,b   Salamon, Douglas ^d   Leber, Amy ^d,e   Tondella, Maria Lucia ^b   Tatti, Kathleen ^b   Spicer, Kevin ^d,e   Emanuel, Allen ^f   Koch, Elizabeth ^f   McGlone, Londell ^b   Pawloski, Lucia ^b   Lemaile Williams, Mysheika ^f   Tucker, Naomi ^f   Iyer, Radhika ^g   Clark, Thomas A ^b   Diorio, Mary ^c   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c OHIO DEPARTMENT OF HEALTH   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f USA   (United States)

^g Franklin County Engineers   (United States)

Author keywords

Bordetella holmesii; Bordetella pertussis; outbreak; PCR; pertussis

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN;

ADOLESCENT; ADULT; BORDETELLA HOLMESII; BORDETELLA PERTUSSIS; CHILD; CLINICAL FEATURE; COUGHING; DEMOGRAPHY; DISEASE SURVEILLANCE; EPIDEMIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; NASOPHARYNX; NONHUMAN; PERTUSSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SEROLOGY; SYMPTOM; UNITED STATES; VACCINATION; VOMITING;

ADOLESCENT; ANTIBODIES, BACTERIAL; BACTERIAL TYPING TECHNIQUES; BORDETELLA; BORDETELLA PERTUSSIS; CHILD; DISEASE OUTBREAKS; DNA, BACTERIAL; HUMANS; NASOPHARYNX; OHIO; PERTUSSIS TOXIN; POLYMERASE CHAIN REACTION; WHOOPING COUGH;

EID: 84872322492     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis888     Document Type: Review

References (32)

1. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1424-6.
2. Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med 2012; 166:6.
3. Watanabe M, Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2004; 2:447-54.
4. Wernli D, Emonet S, Schrenzel J, Harbarth S. Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clin Microbiol Infect 2011; 17:201-3.
5. Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995; 33:1-7.
6. Tang YW, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, Persing DH. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis 1998; 26:389-92.
7. Lindquist SW, Weber DJ, Mangum ME, Hollis DG, Jordan J. Bordetella holmesii sepsis in an asplenic adolescent. Pediatr Infect Dis J 1995; 14:813-5.
8. Morris JT, Myers M. Bacteremia due to Bordetella holmesii. Clin Infect Dis 1998; 27:912-3.
9. Shepard CW, Daneshvar MI, Kaiser RM, et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis 2004; 38:799-804.
10. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis- like symptoms. Emerg Infect Dis 1999; 5:441-3.
11. Guthrie JL, Robertson AV, Tang P, Jamieson F, Drews SJ. Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with pertussis-like symptoms in Ontario, Canada. J Clin Microbiol 2010; 48:1435-7.
12. Mazengia E, Silva EA, Peppe JA, Timperi R, George H. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains. J Clin Microbiol 2000; 38:2330-3.
13. Weber DJ, Miller MB, Brooks RH, Brown VM, Rutala WA. Healthcare worker with "pertussis": consequences of a false-positive polymerase chain reaction test result. Infect Control Hosp Epidemiol 2010; 31:306-7.
14. Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guillot S, Guiso N. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J Clin Microbiol 2011; 49:4347-8.
15. Mooi FR, Bruisten S, Linde I, et al. Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in the Netherlands. FEMS Immunol Med Microbiol 2012; 64:289-91.
16. Glare EM, Paton JC, Premier RR, Lawrence AJ, Nisbet IT. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol 1990; 28:1982-7.
17. Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003; 35:32-40.
18. Reischl U, Lehn N, Sanden GN, Loeffelholz MJ. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol 2001; 39:1963-6.
19. Muyldermans G, Soetens O, Antoine M, et al. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol 2005; 43:30-5.
20. Register KB, Sanden GN. Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol 2006; 44:4577-83.
21. Antila M, He Q, de Jong C, et al. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol 2006; 55(Pt 8):1043-51.
22. Locht C, Keith JM. Pertussis toxin gene: nucleotide sequence and genetic organization. Science 1986; 232:1258-64.
23. Tatti KM, Sparks KN, Boney KO, Tondella ML. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol 2011; 49:4059-66.
24. Centers for Disease Control and Prevention. Bridged-race population estimates, United States, July 1 resident population by state, county, age, sex, bridged-race, and Hispanic origin, on CDC WONDER on-line database. Available at: http://wonder.cdc.gov/. Accessed 15 January 2012.
25. Ohio Disease Reporting System. In: Health ODo, ed, 2006. Available at: http://www.odh.ohio.gov/healthstats/elr/odrs1.aspx. Accessed 29 October 2012.
26. Centers for Disease Control and Prevention and Council of State and Territorial Epidemiologists (CSTE). Pertussis case definition. MMWR Recomm Rep 2006; 5(RR-17):Appendix B.
27. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-3):1-34.
28. Menzies SL, Kadwad V, Pawloski LC, et al. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin Vaccine Immunol 2009; 16:1781-8.
29. Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11:1045-53.
30. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22:742-6.
31. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13 through 17 years - United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:671-77.
32. Riffelmann M, Wirsing von Konig CH, Caro V, Guiso N. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005; 43:4925-9.